Amsterdam Neuroscience
Research highlights
-
Stopping the progression of MS
Why do people with MS continue to deteriorate? How can disease progression be stopped? The researchers at the MS Center Amsterdam want to find answers to these questions.
Amsterdam Neuroscience
-
New, rational therapy decisions for developmental brain disorders
The NWA supported NewTDec* consortium takes on the challenge to inform, perform and monitor rational treatments at the patient ‘N-of-1’ level.
Amsterdam Neuroscience
-
Nationwide study on community-acquired bacterial meningitis: from genetics to therapy
Genetic studies have provided important clues to which mechanisms play a role in the response to the bacteria and secondary damage to the brain.
Amsterdam Neuroscience
-
Personalized MS Treatment
The MS Center Amsterdam want to enable personalized treatments for people with MS. Therefore it is important to know which patient responds best to which medicine.
Amsterdam Neuroscience
-
EEG controlled triage in the ambulance for acute ischemic stroke
Endovascular stroke treatment is effective, but performed in selected hospitals. Pre-hospital identification helps paramedics to choose the right hospital.
Amsterdam Neuroscience
- New treatment strategies for depression by targeting childhood trauma The new research project RESET (REStoring mood after Early life Trauma) aims to alleviate depression in patients with depression and childhood trauma.
-
ABIDE: Alzheimer’s Biomarkers in Daily Practice
To translate diagnostic tests in Alzheimer’s disease (AD) and their related biomarkers’ values to daily practice in local memory clinics.
Amsterdam Neuroscience